Market Research Logo

Global Anti-inflammatory Therapeutics Market 2017-2021

Global Anti-inflammatory Therapeutics Market 2017-2021

About Anti-Inflammatory Therapeutics

Inflammation is a part of immune response triggered against harmful stimuli, foreign objects, damaged cells, irritants, and pathogens in the body. The drugs used to treat these symptoms are called anti-inflammatory drugs. It causes the elimination of the initial cause of cell injury, clearance of dead or necrotic cells, and damaged tissue from the site of the inflammatory process and initiates tissue repair.

Technavio’s analysts forecast the global anti-inflammatory therapeutics market to grow at a CAGR of 6.10% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global anti-inflammatory therapeutics market for 2017-2021. To calculate the market size, the report considers sales of branded, off-label, and generic drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Anti-Inflammatory therapeutics market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AbbVie
  • Amgen
  • Johnson & Johnson
  • Pfizer
Other prominent vendors
  • Boehringer Ingelheim
  • Eli Lilly
  • Novartis
Market driver
  • Availability of targeted therapy
  • For a full, detailed list, view our report
Market challenge
  • Complex regulatory approval process for biosimilars
  • For a full, detailed list, view our report
Market trend
  • Emergence of novel anti-inflammatory drugs
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Anti-Inflammatory therapeutics market 2017-2021

Technavio recognizes the following companies as the key players in the global anti-inflammatory therapeutics market: AbbVie, Amgen, Johnson & Johnson, and Pfizer.

Other Prominent Vendors in the market are: Boehringer Ingelheim, Eli Lilly, and Novartis.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is emergence of novel anti-inflammatory drugs. Cytokines are proteins produced by immune cells. These protein molecules facilitate communication between cells and play a pivotal role in cell development and differentiation including regulation of immune response.”

According to the report, one driver in the market is availability of targeted therapy. The global anti-inflammatory therapeutics market is no stranger to biologics. The biologics are macromolecules, consisting of genetically engineered protein derived from living cells. As biologics can be produced by using DNA recombinant technology, they offer targeted therapy and can also be modified depending on patient's need. Owing to their benefits over other small molecules, biologics are dominating the global anti-inflammatory therapeutics market with more than 60% of market share in 2016.

Further, the report states that one challenge in the market is complex regulatory approval process for biosimilars. The Federal Food, Drug, and Cosmetic Act, regulated by the US FDA state that a biosimilar should be highly similar to the reference biologic drug, in terms of safety and efficacy profile. Moreover, the biosimilar drug should be interchangeable with the reference biologic drug without causing any significant difference in the patient and should not require any intervention by the doctor, who prescribes the reference biologic drug.



Companies Mentioned

AbbVie, Amgen, Johnson & Johnson, Pfizer, Boehringer Ingelheim, Eli Lilly, and Novartis.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
      • Table Market segmentation of global autoimmune disease market by drug class
      • Table Snapshot of drivers and challenges present in the market
      • Table Global anti-inflammatory therapeutics market snapshot
  • Inflammation: An overview
  • Market landscape
    • Market overview
      • Table Global anti-inflammatory therapeutics market revenue 2016-2021 ($ millions)
      • Table Opportunity analysis in global anti-inflammatory therapeutics market
    • Five forces analysis
      • Table Five forces analysis
  • Key clinical trial
    • Table Pipeline snapshot
    • Table Pipeline landscape
    • Table Purpose of clinical trial
  • Market segmentation by application
    • Table Global anti-inflammatory therapeutics market segmentation based on application
    • Table Global anti-inflammatory therapeutics market based on application 2016 (%)
    • RA
      • Table Risk factors responsible for RA
      • Table National arthritis prevalence rate in the US 2000-2040
      • Table Drivers and challenges of global anti-inflammatory RA therapeutics market 2016
      • Table Global anti-inflammatory RA therapeutics market revenue 2016-2021 ($ millions)
    • Psoriasis
      • Table Drivers and challenges of global anti-inflammatory psoriasis therapeutics market 2016
      • Table Global anti-inflammatory psoriasis therapeutics market 2016-2021 ($ millions)
    • MS
      • Table Drivers and challenges of global anti-inflammatory MS therapeutics market 2016
      • Table Global anti-inflammatory MS therapeutics market 2016-2021 ($ millions)
  • Market segmentation by drug class
    • Table Global anti-inflammatory therapeutics market segmentation based on drug class
    • Table Global anti-inflammatory therapeutics market segmentation based on drug class 2016 (%)
    • Anti-inflammatory biologicals
      • Table Marketed anti-inflammatory biologicals
      • Table Global anti-inflammatory biologicals therapeutics market 2016-2021 ($ millions)
    • NSAIDs
      • Table NSAIDs used for the treatment of autoimmune diseases
      • Table Global anti-inflammatory NSAIDs therapeutics market 2016-2021 ($ millions)
    • Corticosteroids
      • Table Global anti-inflammatory corticosteroid therapeutics market 2016-2021 ($ millions)
  • Geographical segmentation
    • Table Global anti-inflammatory therapeutics market based on geography 2016 and 2021 (%)
    • Table Global anti-inflammatory therapeutics market based on geography 2016-2021 ($ millions)
    • Table Global anti-inflammatory therapeutics market based on geography 2016-2021 (%)
    • Anti-inflammatory therapeutics market in Americas
      • Table Market scenario in Americas
      • Table Anti-inflammatory therapeutics market in Americas 2016-2021 ($ millions)
    • Anti-inflammatory therapeutics market in EMEA
      • Table Market scenario in EMEA
      • Table Anti-inflammatory therapeutics market in EMEA 2016-2021 ($ millions)
    • Anti-inflammatory therapeutics market in APAC
      • Table Market scenario in APAC
      • Table Anti-inflammatory therapeutics market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Prevalence rate of types of IBD in the US 2015
      • Table Incidence rate of types of IBD in the US 2015
      • Table Biologics approvals by the US FDA to treat autoimmune diseases
      • Table Commonly used off-label anti-inflammatory therapeutics
    • Market challenges
  • Market trends
    • Emergence of novel anti-inflammatory drugs
      • Table Ongoing clinical trials with JAK inhibitors
    • Increasing strategic alliances by vendors
    • Advent of biosimilars
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global anti-inflammatory therapeutics market 2016
      • Table Competitive landscape snapshot
  • Key vendor analysis
    • AbbVie
      • Table AbbVie: Key highlights
      • Table AbbVie: Strength assessment
      • Table AbbVie: Strategy assessment
      • Table AbbVie: Opportunity assessment
    • Amgen
      • Table Amgen: Key highlights
      • Table Amgen: Strength assessment
      • Table Amgen: Strategy assessment
      • Table Amgen: Opportunity assessment
    • Johnson & Johnson
      • Table Johnson & Johnson: Key highlights
      • Table Johnson & Johnson: Strength assessment
      • Table Johnson & Johnson: Strategy assessment
      • Table Johnson & Johnson: Opportunity assessment
    • Pfizer
      • Table Pfizer: Key highlights
      • Table Pfizer: Strength assessment
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report